U.S. pharma giant copyright scrapped two experimental weight loss pills last 12 months—a once-every day capsule, lotiglipron, resulting from elevated liver enzymes plus a 2 times-day by day tablet, danuglipron, resulting from potent Uncomfortable side effects—but CEO Albert Bourla has stated the company is set to “play and win” while in the